Results 101 to 110 of about 42,003 (250)

Coexistence of Ovarian Mucinous Adeno Carcinoma and Benign Brenner Tumor: A Case Report

open access: yesGynecology Obstetrics & Reproductive Medicine, 2011
Mucinous ovarian tumors are known to coexist sometimes with Brenner tumors; however, in many of the cases in the literature, mucinous cystadenomas are seen to have been analyzed.
Özlem Seçilmiş Kerimoğlu   +3 more
doaj  

Interobserver variability of histopathological assessment in pT1 colorectal carcinoma

open access: yesHistopathology, EarlyView.
Interobserver variability among 20 gastrointestinal pathologists was evaluated on 80 pT1 colorectal carcinoma cases. A pilot phase was followed by a consensus meeting, then a larger concordance study was performed. High interobserver agreement was achieved after consensus for histological grade, lymphovascular invasion, tumour budding, poorly ...
Karmele Saez de Gordoa   +24 more
wiley   +1 more source

RB1 inactivation in cutaneous carcinomas

open access: yesHistopathology, EarlyView.
Among skin carcinomas, recurrent RB1 inactivation is observed in Merkel cell carcinoma, in a subset of squamous cell carcinoma with bowenoid morphology, in sebaceous carcinoma and in the recently described Wnt/beta‐catenin rosette‐forming carcinoma.
Tiffany Liv   +8 more
wiley   +1 more source

Claudin‐18 expression in gastric type adenocarcinoma and HPV‐associated adenocarcinoma of the uterine cervix

open access: yesHistopathology, EarlyView.
CLDN18 (43‐14A) is expressed in most gastric type adenocarcinomas and a much smaller proportion of HPV‐associated adenocarcinomas. Expression of CLDN18.2 mRNA but not CLDN18.1 mRNA is confirmed in both gastric type adenocarcinomas and HPV‐associated adenocarcinomas.
Nobuko Yasutake   +12 more
wiley   +1 more source

Optimized workup of lymph nodes in regard to UICC classification of colorectal carcinoma

open access: yesHistopathology, EarlyView.
Treatment and outcome of colon cancer depend significantly on the histopathological examination of lymph nodes. Methodologically, stepwise sectioning and immunohistochemistry are the primary methods used. The extent of this examination is subject to debate but should be maintained at an adequate level in routine laboratory work.
Moritz Rust   +6 more
wiley   +1 more source

mpMRI features of mucinous prostate cancer: two case reports

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine
Background Mucinous adenocarcinoma of the prostate (MACP) is one of the rarest variants of prostatic neoplasm, with more aggressive behavior than non-mucinous prostatic cancer.
Giuseppe Chiacchio   +10 more
doaj   +1 more source

The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges

open access: yesHistopathology, EarlyView.
Invasive breast carcinomas with papillary features (IBCP) comprise diverse subtypes with variable architecture, histopathology, and clinical behaviour. This review outlines evolving classification, diagnostic criteria, and treatment implications, highlighting challenges in distinguishing in situ from invasive lesions. Standardised diagnostic approaches
Emad A Rakha   +2 more
wiley   +1 more source

Supplementary Data from FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1

open access: gold, 2023
Mijung Kwon   +10 more
openalex   +1 more source

Aquaporin‐1 differentiates intrahepatic cholangiocarcinoma from liver metastases of pancreatic ductal adenocarcinoma

open access: yesHistopathology, EarlyView.
Differentiating intrahepatic CCA from PDAC metastatic to the liver is critical for the clinical management of patients with pancreatobiliary cancers. AQP1 has demonstrated an excellent discriminatory performance in this clinical scenario. Aims Differentiating intrahepatic cholangiocarcinoma (iCCA) from metastatic ductal adenocarcinoma of the pancreas ...
Leoncini Giuseppe   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy